Stay updated on Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page.

Latest updates to the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page
- Check2 days agoChange DetectedA new revision entry v3.5.3 was added to the study's record history, and the previous revision v3.5.2 was removed. This updates the visible version history to reflect the latest page revision.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded revision v3.5.2 and removed revision v3.5.0 from the history.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check45 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed from the page history.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision v3.4.3 has been added and revision v3.4.2 has been removed from the history.SummaryDifference0.1%

- Check80 days agoChange DetectedThe study history shows an added site revision entry (v3.4.2) and the removal of an older funding/operating status notice (v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check87 days agoChange DetectedThe page adds a site-wide funding notice and records a new revision (v3.4.1) with a Study Status entry, while removing the prior revision (v3.4.0).SummaryDifference0.7%

Stay in the know with updates to Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page.